Do analysts recommend ZJYL or MLSS?

Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 125.23%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable earnings & valuation, ZJYL or MLSS?

Jin Medical International has higher revenue and earnings than Milestone Scientific. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 7.85 $1.19M N/A N/A Milestone Scientific $9.42M 4.27 -$6.93M -$0.04 N/A

Do analysts prefer MLSS or INGN?

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 125.23%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Milestone Scientific (MLSS) Competitors

$0.44 +0.01 (+2.28%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.42 -0.03 (-6.08%)

As of 09/11/2026 08:00 PM Eastern

Compare

MLSS vs. ZJYL, FOCL, KRMD, OWLT, and INGN

Should you buy Milestone Scientific stock or one of its competitors? Milestone Scientific's main competitors and comparable companies include Jin Medical International (ZJYL), FocalTherics (FOCL), KORU Medical Systems (KRMD), Owlet (OWLT), and Inogen (INGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Milestone Scientific compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

5.8% of Milestone Scientific shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 125.23%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Jin Medical International has higher revenue and earnings than Milestone Scientific.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	7.85	$1.19M	N/A	N/A
Milestone Scientific	$9.42M	4.27	-$6.93M	-$0.04	N/A

In the previous week, Jin Medical International had 3 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Jin Medical International and 0 mentions for Milestone Scientific. Jin Medical International's average media sentiment score of 1.10 beat Milestone Scientific's score of 0.00 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Overall Sentiment
Jin Medical International	Positive
Milestone Scientific	Neutral

Jin Medical International has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Jin Medical International's return on equity of 0.00% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Milestone Scientific	-52.01%	-60.26%	-40.23%

Jin Medical International has a beta of 7.31, indicating that its share price is 631% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Summary

Jin Medical International beats Milestone Scientific on 9 of the 14 factors compared between the two stocks.

How does Milestone Scientific compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

FocalTherics presently has a consensus target price of $7.75, suggesting a potential upside of 89.02%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 125.23%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Milestone Scientific is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Milestone Scientific has lower revenue, but higher earnings than FocalTherics. Milestone Scientific is trading at a lower price-to-earnings ratio than FocalTherics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.18	-$29.25M	-$1.03	N/A
Milestone Scientific	$9.42M	4.27	-$6.93M	-$0.04	N/A

FocalTherics has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

In the previous week, FocalTherics had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for FocalTherics and 0 mentions for Milestone Scientific. FocalTherics' average media sentiment score of 1.45 beat Milestone Scientific's score of 0.00 indicating that FocalTherics is being referred to more favorably in the media.

Company	Overall Sentiment
FocalTherics	Positive
Milestone Scientific	Neutral

62.7% of FocalTherics shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 10.1% of FocalTherics shares are held by insiders. Comparatively, 9.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Milestone Scientific has a net margin of -52.01% compared to FocalTherics' net margin of -56.26%. Milestone Scientific's return on equity of -60.26% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Summary

Milestone Scientific beats FocalTherics on 9 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

KORU Medical Systems has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

KORU Medical Systems presently has a consensus target price of $7.00, suggesting a potential upside of 121.52%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 125.23%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

KORU Medical Systems has a net margin of -4.03% compared to Milestone Scientific's net margin of -52.01%. KORU Medical Systems' return on equity of -10.63% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Milestone Scientific	-52.01%	-60.26%	-40.23%

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 9.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

KORU Medical Systems has higher revenue and earnings than Milestone Scientific. KORU Medical Systems is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.53	-$2.64M	-$0.04	N/A
Milestone Scientific	$9.42M	4.27	-$6.93M	-$0.04	N/A

In the previous week, KORU Medical Systems had 5 more articles in the media than Milestone Scientific. MarketBeat recorded 5 mentions for KORU Medical Systems and 0 mentions for Milestone Scientific. KORU Medical Systems' average media sentiment score of 1.88 beat Milestone Scientific's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Very Positive
Milestone Scientific	Neutral

Summary

KORU Medical Systems beats Milestone Scientific on 10 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Owlet?

Milestone Scientific (NYSE:MLSS) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Milestone Scientific has higher earnings, but lower revenue than Owlet. Milestone Scientific is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$9.42M	4.27	-$6.93M	-$0.04	N/A
Owlet	$105.70M	1.30	-$39.68M	-$0.75	N/A

Milestone Scientific has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Owlet has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by insiders. Comparatively, 36.2% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Milestone Scientific currently has a consensus price target of $1.00, indicating a potential upside of 125.23%. Owlet has a consensus price target of $15.00, indicating a potential upside of 220.17%. Given Owlet's higher possible upside, analysts clearly believe Owlet is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Owlet's average media sentiment score of 0.36 beat Milestone Scientific's score of 0.00 indicating that Owlet is being referred to more favorably in the news media.

Company	Overall Sentiment
Milestone Scientific	Neutral
Owlet	Neutral

Owlet has a net margin of -8.61% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Owlet	-8.61%	-601.24%	-15.96%

Summary

Owlet beats Milestone Scientific on 10 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Inogen?

Milestone Scientific (NYSE:MLSS) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 125.23%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Inogen had 3 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Inogen and 0 mentions for Milestone Scientific. Inogen's average media sentiment score of 1.36 beat Milestone Scientific's score of 0.00 indicating that Inogen is being referred to more favorably in the news media.

Company	Overall Sentiment
Milestone Scientific	Neutral
Inogen	Positive

Milestone Scientific has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, Inogen has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market.

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Comparatively, 2.5% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Milestone Scientific has higher earnings, but lower revenue than Inogen. Milestone Scientific is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$9.42M	4.27	-$6.93M	-$0.04	N/A
Inogen	$354.30M	0.40	-$22.75M	-$0.90	N/A

Inogen has a net margin of -6.94% compared to Milestone Scientific's net margin of -52.01%. Inogen's return on equity of -13.17% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Inogen	-6.94%	-13.17%	-8.36%

Summary

Inogen beats Milestone Scientific on 10 of the 17 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLSS vs. The Competition

Export

Metric	Milestone Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$40.25M	$5.48B	$7.17B	$23.39B
Dividend Yield	N/A	1.79%	2.57%	3.56%
P/E Ratio	-6.34	25.09	274.94	28.71
Price / Sales	4.27	71.54	685.45	21.10
Price / Cash	N/A	32.57	76.65	34.17
Price / Book	4.04	5.97	10.33	4.74
Net Income	-$6.93M	$150.75M	$3.50B	$1.07B
7 Day Performance	-5.37%	-2.83%	-3.32%	-2.00%
1 Month Performance	-16.10%	-3.09%	-0.41%	-2.69%
1 Year Performance	-24.75%	9.34%	19.21%	10.45%

Milestone Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLSS Milestone Scientific	1.4206 of 5 stars	$0.44 +2.3%	$1.00 +125.2%	-24.7%	$40.25M	$9.42M	N/A	30
ZJYL Jin Medical International	1.2805 of 5 stars	$2.08 -3.3%	N/A	-83.6%	$163.14M	$20.69M	N/A	245	Positive News Short Interest Decrease
FOCL FocalTherics	4.2641 of 5 stars	$4.15 -0.5%	$7.75 +86.7%	N/A	$155.74M	$70.53M	N/A	230
KRMD KORU Medical Systems	3.9198 of 5 stars	$3.25 +0.9%	$7.00 +115.4%	-19.4%	$149.28M	$41.13M	N/A	80	News Coverage Insider Trade
OWLT Owlet	2.501 of 5 stars	$5.00 -0.6%	$15.00 +200.0%	-32.8%	$145.53M	$105.70M	N/A	106	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Milestone Scientific (MLSS) Competitors

MLSS vs. ZJYL, FOCL, KRMD, OWLT, and INGN

How does Milestone Scientific compare to Jin Medical International?

Summary

How does Milestone Scientific compare to FocalTherics?

Summary

How does Milestone Scientific compare to KORU Medical Systems?

Summary

How does Milestone Scientific compare to Owlet?

Summary

How does Milestone Scientific compare to Inogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Milestone Scientific (MLSS) Competitors

MLSS vs. ZJYL, FOCL, KRMD, OWLT, and INGN

How does Milestone Scientific compare to Jin Medical International?

Do institutionals & insiders have more ownership in ZJYL or MLSS?

Do analysts recommend ZJYL or MLSS?

Which has preferable earnings & valuation, ZJYL or MLSS?

Does the media prefer ZJYL or MLSS?

Is ZJYL or MLSS more profitable?

Which has more volatility and risk, ZJYL or MLSS?

Summary

How does Milestone Scientific compare to FocalTherics?

Do analysts rate FOCL or MLSS?

Which has preferable earnings and valuation, FOCL or MLSS?

Which has more risk and volatility, FOCL or MLSS?

Does the media refer more to FOCL or MLSS?

Do insiders & institutionals have more ownership in FOCL or MLSS?

Is FOCL or MLSS more profitable?

Summary

How does Milestone Scientific compare to KORU Medical Systems?

Which has more volatility & risk, KRMD or MLSS?

Do analysts rate KRMD or MLSS?

Is KRMD or MLSS more profitable?

Do institutionals & insiders have more ownership in KRMD or MLSS?

Which has higher valuation & earnings, KRMD or MLSS?

Does the media prefer KRMD or MLSS?

Summary

How does Milestone Scientific compare to Owlet?

Which has better valuation and earnings, MLSS or OWLT?

Which has more risk and volatility, MLSS or OWLT?

Do institutionals and insiders believe in MLSS or OWLT?

Do analysts rate MLSS or OWLT?

Does the media favor MLSS or OWLT?

Is MLSS or OWLT more profitable?

Summary

How does Milestone Scientific compare to Inogen?

Do analysts prefer MLSS or INGN?

Does the media prefer MLSS or INGN?

Which has more risk & volatility, MLSS or INGN?

Do institutionals and insiders have more ownership in MLSS or INGN?

Which has preferable valuation & earnings, MLSS or INGN?

Is MLSS or INGN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools